Showing 1 - 9 results of 9 for search 'Violaine Giraud', query time: 0.03s
Refine Results
-
1
-
2
Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab. by Coraline Dumenil, Marie-Ange Massiani, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Etienne Giroux Leprieur
Published 2018-01-01
Article -
3
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer by Etienne Giroux Leprieur, Guillaume Herbretau, Coraline Dumenil, Catherine Julie, Violaine Giraud, Sylvie Labrune, Jennifer Dumoulin, Julie Tisserand, Jean-François Emile, Hélène Blons, Thierry Chinet
Published 2018-05-01
Article -
4
Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer by Camille Mehlman, Paul Takam Kamga, Adrien Costantini, Catherine Julié, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Published 2021-03-01
Article -
5
Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab by Adrien Costantini, Catherine Julie, Coraline Dumenil, Zofia Hélias-Rodzewicz, Julie Tisserand, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Published 2018-08-01
Article -
6
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors by Adrien Costantini, Paul Takam Kamga, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Martin Rottman, Jean-François Emile, Etienne Giroux Leprieur
Published 2020-12-01
Article -
7
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients. by Philippine Dacosta-Noble, Adrien Costantini, Coraline Dumenil, Jennifer Dumoulin, Pierre Helly de Tauriers, Violaine Giraud, Sylvie Labrune, Jean-François Emile, Jean-Claude Alvarez, Thierry Chinet, Etienne Giroux Leprieur
Published 2019-01-01
Article -
8
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab by Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Dumenil, Nathalie Neveux, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Julie Tisserand, Catherine Julie, Jean-François Emile, Thierry Chinet, Etienne Giroux Leprieur
Published 2019-07-01
Article -
9
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal? by Lucile Sesé, Lucile Sesé, Lucile Sesé, Lucile Sesé, Hilario Nunes, Hilario Nunes, Vincent Cottin, Dominique Israel-Biet, Bruno Crestani, Stephanie Guillot-Dudoret, Jacques Cadranel, Benoit Wallaert, Abdellatif Tazi, Bernard Maître, Gregoire Prévot, Sylvain Marchand-Adam, Sandrine Hirschi, Sandra Dury, Violaine Giraud, Violaine Giraud, Anne Gondouin, Philippe Bonniaud, Julie Traclet, Karine Juvin, Raphael Borie, Zohra Carton, Olivia Freynet, Thomas Gille, Thomas Gille, Carole Planès, Carole Planès, Dominique Valeyre, Dominique Valeyre, Yurdagül Uzunhan, Yurdagül Uzunhan
Published 2021-08-01
Article